Back to Search Start Over

Registrational dataset from the phase 1/2 ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion plus non-small-cell lung cancer (NSCLC)

Authors :
Thomas, M.
Griesinger, F.
Schuler, Martin
Gainor, J. F.
Curigliano, G.
Kim, D.-W.
Lee, D. H.
Besse, B.
Baik, C. S.
Doebele, R. C.
Cassier, P.
Lopes, G.
Tan, D. S.-W.
Garralda, E.
Paz-Ares, L.
Chul Cho, B.
Gadgeel, S. M.
Liu, S. V.
Turner, C. D.
Subbiah, V.
Publication Year :
2020

Subjects

Subjects :
Medizin

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.unidue...bib..594a41f55a97fc4f28b34b1e212133d3

Tools

Authors Abstract Subjects Details